Pheochromocytoma (PHEO) and Paraganglioma (PGL)
This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some no...
Saved in:
| : | |
|---|---|
| Year of Publication: | 2019 |
| Language: | English |
| Physical Description: | 1 electronic resource (380 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993548163504498 |
|---|---|
| ctrlnum |
(CKB)4100000010106278 (oapen)https://directory.doabooks.org/handle/20.500.12854/56155 (EXLCZ)994100000010106278 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Pacak, Karel auth Pheochromocytoma (PHEO) and Paraganglioma (PGL) Pheochromocytoma MDPI - Multidisciplinary Digital Publishing Institute 2019 1 electronic resource (380 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment. English polycythemia peptide receptor radiotherapy vasculogenesis catecholamines neuroendocrine GTV adaptive immunity therapy resistance histology transgenic mice cryoablation spheroids energy metabolism somatostatinoma angiogenesis pheochromocytoma SDHD percutaneous ethanol injection metanephrines SDHB global longitudinal strain mutation normetanephrines catecholamine PASS PGL 177Lu-DOTATATE chromosomal alteration speckle-tracking echocardiography lL-6 dog percutaneous ablation stem-like tumor cells EPAS1 neural crest fluorescence imaging neutrophil xenograft inflammation head and neck weighted standard deviation FGF21 calorimetry HIF average real variability next-generation sequencing adrenocortical carcinoma carotid body hypoxia-inducible factor paraganglioma succinate dehydrogenase blood pressure variability arrhythmia mortality NF1 toll-like receptor GAPP NET subclinical systolic dysfunction pheochromocytoma and paraganglioma PET-CT pan-cancer analysis mouse pheochromocytoma cells innate immunity neurogenesis neuroendocrine tumor obesity hypotension hypoxia CNV detection 18F-FDOPA comparative genomics adrenomedullary function PCC pathogen-associated molecular patterns adrenal tumor radiotherapy 11C-hydroxy-ephedrine radiofrequency ablation PPGL minimally invasive procedure sporadic diabetes mellitus adrenal incidentaloma germline mutation immunotherapy VHL immunohistochemistry metastatic OR malignant pheochromocytoma erythropoietin postoperative targeted therapy PRRT metastatic mitochondria T cell TCA cycle meta-analysis pseudohypoxia ectopic secretion radiosensitization chromogranin A hereditary hypertension PET phosphorylation tyrosine hydroxylase 3-03921-654-6 Taïeb, David auth |
| language |
English |
| format |
eBook |
| author |
Pacak, Karel |
| spellingShingle |
Pacak, Karel Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| author_facet |
Pacak, Karel Taïeb, David |
| author_variant |
k p kp |
| author2 |
Taïeb, David |
| author2_variant |
d t dt |
| author_sort |
Pacak, Karel |
| title |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_full |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_fullStr |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_full_unstemmed |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_auth |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_alt |
Pheochromocytoma |
| title_new |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| title_sort |
pheochromocytoma (pheo) and paraganglioma (pgl) |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2019 |
| physical |
1 electronic resource (380 p.) |
| isbn |
3-03921-655-4 3-03921-654-6 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT pacakkarel pheochromocytomapheoandparagangliomapgl AT taiebdavid pheochromocytomapheoandparagangliomapgl AT pacakkarel pheochromocytoma AT taiebdavid pheochromocytoma |
| status_str |
n |
| ids_txt_mv |
(CKB)4100000010106278 (oapen)https://directory.doabooks.org/handle/20.500.12854/56155 (EXLCZ)994100000010106278 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1787551667482263552 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05185nam-a2201561z--4500</leader><controlfield tag="001">993548163504498</controlfield><controlfield tag="005">20231214133452.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-655-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106278</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/56155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106278</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pacak, Karel</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pheochromocytoma (PHEO) and Paraganglioma (PGL)</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Pheochromocytoma </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (380 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polycythemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide receptor radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vasculogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">catecholamines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuroendocrine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GTV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adaptive immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapy resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">histology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transgenic mice</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cryoablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spheroids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">energy metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">somatostatinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pheochromocytoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SDHD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">percutaneous ethanol injection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metanephrines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SDHB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">global longitudinal strain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mutation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">normetanephrines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">catecholamine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PASS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PGL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">177Lu-DOTATATE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chromosomal alteration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">speckle-tracking echocardiography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lL-6</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dog</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">percutaneous ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stem-like tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EPAS1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neural crest</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorescence imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutrophil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">xenograft</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">head and neck</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">weighted standard deviation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FGF21</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">calorimetry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">average real variability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next-generation sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenocortical carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carotid body</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypoxia-inducible factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paraganglioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">succinate dehydrogenase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood pressure variability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mortality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NF1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toll-like receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GAPP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">subclinical systolic dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pheochromocytoma and paraganglioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET-CT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pan-cancer analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mouse pheochromocytoma cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">innate immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuroendocrine tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypotension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypoxia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CNV detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">18F-FDOPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">comparative genomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenomedullary function</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PCC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathogen-associated molecular patterns</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenal tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">11C-hydroxy-ephedrine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiofrequency ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PPGL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">minimally invasive procedure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sporadic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenal incidentaloma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">germline mutation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VHL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunohistochemistry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic OR malignant pheochromocytoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">erythropoietin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">postoperative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PRRT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastatic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mitochondria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TCA cycle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">meta-analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pseudohypoxia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ectopic secretion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiosensitization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chromogranin A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hereditary</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phosphorylation tyrosine hydroxylase</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-654-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taïeb, David</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:54:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338741640004498&Force_direct=true</subfield><subfield code="Z">5338741640004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338741640004498</subfield></datafield></record></collection> |